Cardinal Health, Inc. (LON:0HTG)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 38.10B |
| Revenue (ttm) | 174.31B |
| Net Income (ttm) | 1.19B |
| Shares Out | n/a |
| EPS (ttm) | 4.93 |
| PE Ratio | 32.11 |
| Forward PE | 21.12 |
| Dividend | 1.55 (0.73%) |
| Ex-Dividend Date | Oct 1, 2025 |
| Volume | 162 |
| Average Volume | 692 |
| Open | 212.99 |
| Previous Close | 214.43 |
| Day's Range | 212.41 - 217.96 |
| 52-Week Range | 114.74 - 218.17 |
| Beta | 0.64 |
| RSI | 79.50 |
| Earnings Date | Jan 29, 2026 |
About Cardinal Health
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.... [Read more]
Financial Performance
In 2025, Cardinal Health's revenue was $222.58 billion, a decrease of -1.87% compared to the previous year's $226.83 billion. Earnings were $1.56 billion, an increase of 83.22%.
Financial numbers in USD Financial StatementsNews
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Cardinal (CAH) Upgraded to Buy: Here's Why
Cardinal (CAH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Stop Sleeping on These 3 Stocks (Seriously)
Cardinal Health gained nearly 74% year to date, and it has the potential to keep climbing. Loews doesn't own the most exciting portfolio of businesses, but the conglomerate has been steadily gaining o...
6 Healthcare Stocks With Strong Upward Momentum
Out with the old (tech), in with the new (healthcare). After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of...
6 Healthcare Stocks With Strong Upward Momentum
Out with the old (tech), in with the new (healthcare). After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of...
Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today
Cardinal Health (NYSE: CAH) has outperformed the market over the past 5 years by 17.13% on an annualized basis producing an average annual return of 30.39%. Currently, Cardinal Health has a market ca...
Cardinal Health, Inc. (CAH) Presents at UBS Global Healthcare Conference 2025 Transcript
Cardinal Health, Inc. (CAH) UBS Global Healthcare Conference 2025 November 11, 2025 8:45 AM ESTCompany ParticipantsMatt Sims - Vice President of Investor...
4 Value Stocks With Strong Interest Coverage as Markets Rebound
As Wall Street rebounds on hopes of a shutdown resolution, investors turn to value picks like LTH, CAH, MCK and FLS with strong interest coverage ratios.
Validea Detailed Fundamental Analysis - CAH
Below is Validea's guru fundamental report for CARDINAL HEALTH INC (CAH). Of the 22 guru strategies we follow, CAH rates highest using our Multi-Factor Investor model based on the published strategy o...
Are You Looking for a Top Momentum Pick? Why Cardinal Health (CAH) is a Great Choice
Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...
3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Cardinal Health: Quiet Transformation, Clear Buy
Wells Fargo Raises Price Target for Cardinal Health (CAH) to $221 | CAH Stock News
Wells Fargo Raises Price Target for Cardinal Health (CAH) to $221 | CAH Stock News
Cardinal Health (CAH) Boosts FY 2026 EPS Guidance
Cardinal Health (CAH) Boosts FY 2026 EPS Guidance
Increasing medication access: Charitable clinics and pharmacies to receive share in $1.6 million in Equity Rx grants from Cardinal Health Foundation
Grants are a part of $5 million commitment from Cardinal Health Foundation and awarded by the National Association of Free & Charitable Clinics Grants are a part of $5 million commitment from Cardinal...
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio , Nov. 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital s...
Mizuho Raises Price Target for Cardinal Health (CAH) to $210 | CAH Stock News
Mizuho Raises Price Target for Cardinal Health (CAH) to $210 | CAH Stock News
Cardinal Health (CAH): TD Cowen Raises Price Target to $225 | CAH Stock News
Cardinal Health (CAH): TD Cowen Raises Price Target to $225 | CAH Stock News
Cardinal Health completes acquisition of Solaris Health
Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal Health's MSO platforms to ~3,000 pr...
Cardinal Health CEO says Obamacare subsidies extension under review 'every single day'
Cardinal Health CEO Jason Hollar discusses medication affordability, the Obamacare subsidies battle and more on 'The Claman Countdown.' #fox #media #us #usa #new #news #foxbusiness #healthcare #medici...
Best Dividend Aristocrats For November 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed SPY in 2025, with a 6.27% YTD gain versus SPY's 17.8%. Despite overall underperformance, select Aristocrats like CAT, CAH, CHRW...
Cardinal Health (CAH) Analyst Rating Update: Citigroup Raises Price Target | CAH Stock News
Cardinal Health (CAH) Analyst Rating Update: Citigroup Raises Price Target | CAH Stock News